The content on this site is intended for healthcare professionals only
Dr Elena Zamagni talks to ecancer about autologous stem cell transplant at the 18th EHA Congress in Stockholm, Sweden.
Dr Zamagni highlights the relationship between increasing chemotherapy after transplantation and increasing progression free and overall survival from two clinical trials.
Choosing 1st line TKI Wisely in patients with CML
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic leukaemia
Ponatinib is better than imatinib for frontline treatment of newly diagnosed Ph+ acute lymphoblastic leukaemia
Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM: MRD analysis
Treatment of multiple myeloma in Turkey
The evolving paradigm in management of Multiple Myeloma
Multiple myeloma (A cancer arising from plasma cells)
